Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Archives of Medical Research|May 19, 2019
Neglected Factors Affecting the Burden of TuberculosisAmir Abdoli, Mirza Ali Mofazzal Jahromi
Scientific Reports|August 18, 2022
Considering epitopes conservity in targeting SARS-CoV-2 mutations in variants: a novel immunoinformatics approach to vaccine designMohammad Aref Bagherzadeh, Mohammad Izadi, Kazem Baesi, et al.
Heliyon|December 11, 2023
Hematological, inflammatory, and novel biomarkers assessment as an eminent strategy for clinical management of COVID-19Sanaz Rezaeian, Fatemeh Razmjooei, Masoome Pourmokhtari, et al.
ACS Pharmacology & Translational Science|June 18, 2026
The Prenatal Dilemma: Fever vs Acetaminophen? Navigating a Difficult ChoiceMohammad Darayesh, Elaheh Entezar Almahdi, Mirza Ali Mofazzal Jahromi, et al.
Human Immunology|October 5, 2025
One action and multiple results: Influenza A virus and SARS-CoV-2 poly-epitope-based hybrid vaccine exploration by reverse vaccinology and immunoinformatic methodsFatemeh Razmjooei, Mohammad Izadi, Abbas Dehghanian, et al.
Artificial Cells, Nanomedicine, and Biotechnology|June 7, 2016
Application of arteether-loaded polyurethane nanomicelles to induce immune response in breast cancer modelMona Jabbarzadegan, Hajar Rajayi, Mirza Ali Mofazzal Jahromi, et al.
Clinical and Translational Discovery|January 30, 2023
Latent infections, coronavirus disease 2019 and psychiatric disorders: The friend of my enemyMirza Ali Mofazzal Jahromi, Mina Sefidfard, Ali Taghipour, et al.
BMC Research Notes|December 28, 2024
Evaluation of the hematological parameters, inflammatory biomarkers, and thyroid hormones in hypothyroidism patientsMarzieh Haghbin, Fatemeh Razmjooei, Fatemeh Abbasi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 27, 2021
Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studiesAkbar Hasanzadeh, Masoomeh Alamdaran, Sepideh Ahmadi, et al.
Amino Acids|June 28, 2026
Reprogramming parasitic signatures into anticancer peptide candidates: in silico discovery of Leishmania major-derived peptidesAbbas Dehghanian, Mohammad Izadi, Zahra Minaei, et al.
Pageof 2